CYDX (Cyduct Diagnostics) Gross Margin %: 0.00% (As of . 20)


What is Cyduct Diagnostics Gross Margin %?

Cyduct Diagnostics CYDX +4.22% Gross Margin % is 0.00% as of . 20.

Gross Margin % is calculated as gross profit divided by its revenue. Cyduct Diagnostics's Gross Profit for the three months ended in . 20 was $0.00 Mil. Cyduct Diagnostics's Revenue for the three months ended in . 20 was $0.00 Mil. Therefore, Cyduct Diagnostics's Gross Margin % for the quarter that ended in . 20 was 0.00%. If there's no value for Cost of Goods Sold, then Gross Margin % is not calculated.


The historical rank and industry rank for Cyduct Diagnostics's Gross Margin % or its related term are showing as below:


CYDX's Gross Margin % is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 51.94
* Ranked among companies with meaningful Gross Margin % only.

Cyduct Diagnostics had a gross margin of N/A% for the quarter that ended in . 20 => No sustainable competitive advantage

The 5-Year average Growth Rate of Gross Margin for Cyduct Diagnostics was 0.00% per year.


Cyduct Diagnostics  (OTCPK:CYDX) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Cyduct Diagnostics had a gross margin of N/A% for the quarter that ended in . 20 => No sustainable competitive advantage


Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.


Cyduct Diagnostics Gross Margin % Related Terms


Cyduct Diagnostics Gross Margin % Historical Data

* Premium members only.

The historical data trend for Cyduct Diagnostics's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cyduct Diagnostics Gross Margin % Chart

Cyduct Diagnostics Annual Data
Trend
Gross Margin %

Cyduct Diagnostics Quarterly Data
Gross Margin %

CYDX vs SECI, QTXB, ASNB: Gross Margin % Comparison

For the Medical Devices subindustry, Cyduct Diagnostics's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cyduct Diagnostics Gross Margin % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Cyduct Diagnostics's Gross Margin % distribution charts can be found below:

* The bar in red indicates where Cyduct Diagnostics's Gross Margin % falls into.



Cyduct Diagnostics Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue. (Note that if there's no value for Cost of Goods Sold, then Gross Margin % is not calculated.)

Cyduct Diagnostics's Gross Margin for the fiscal year that ended in . 20 is calculated as

Gross Margin % (A: . 20 )=Gross Profit (A: . 20 ) / Revenue (A: . 20 )
=0 /
=(Revenue - Cost of Goods Sold) / Revenue
=( - ) /
=N/A %

Cyduct Diagnostics's Gross Margin for the quarter that ended in . 20 is calculated as


Gross Margin % (Q: . 20 )=Gross Profit (Q: . 20 ) / Revenue (Q: . 20 )
=0 /
=(Revenue - Cost of Goods Sold) / Revenue
=( - ) /
=N/A %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.

Frequently Asked Questions Learn more about Gross Margin % →
What does a Gross Margin % of 0.00% mean?
Cyduct Diagnostics (CYDX) has a Gross Margin % of 0.00% as of . 20. Gross margin is the ratio of total gross profit to net sales. View historical data on Cyduct Diagnostics and its competitors.
Is Cyduct Diagnostics' Gross Margin % too high?
Cyduct Diagnostics' current Gross Margin % is 0.00%.
How does Cyduct Diagnostics' Gross Margin % compare to SECI and QTXB?
Cyduct Diagnostics' Gross Margin % of 0.00% can be compared against companies in the Medical Devices & Instruments industry. The industry median Gross Margin % is 51.94. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Medical Devices & Instruments company?
The median Gross Margin % among Medical Devices & Instruments companies is 51.94, based on 805 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Cyduct Diagnostics and its competitors. For the Medical Devices & Instruments industry, the median Gross Margin % is 51.94 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cyduct Diagnostics's current Gross Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cyduct Diagnostics stock overvalued right now?
Cyduct Diagnostics (CYDX) has a current Gross Margin % of 0.00%. The current Gross Margin % is 0.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Cyduct Diagnostics (CYDX), the current Gross Margin % is 0.00% as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Cyduct Diagnostics Business Description

Address 1698 Post Road East, Suite 1A, Westport, CT, USA, 06880
Cyduct Diagnostics Inc is a clinical-stage diagnostic company. It focuses on creating and enhancing a portfolio of technologies and assets based on the early assessment and detection of Breast Cancer. Its technology platform of MammoView devices is a single-use, high-margin product that assesses, screens, detects, monitors, and facilitates the treatment of identifiable changes that distinguish variations in breast health. The company markets these products under its Solos Endoscopy brand, along with a line of branded surgical instruments, manufactured by third parties to its design specifications, mainly endoscopes and hand-held surgical instruments for the minimally invasive surgery market.